Anna Maria Pittaluga | Biological Networks | Top Researcher Award

Published on by Network Science

Prof. Anna Maria Pittaluga | Biological Networks | Top Researcher Award

University of Genoa | Italy

Anna Maria Pittaluga is a distinguished pharmacologist with a PhD in Pharmacology and Toxicology from the University of Turin (1990), and MSc degrees in Pharmacy (1983) and in Pharmaceutical Chemistry and Technology with honors (1982) from the University of Genova. She has built a long-standing academic career at the University of Genoa, where she has served as Assistant Professor (1993–2003), Associate Professor (2004–2019), and currently as Full Professor of Pharmacology since 2019. Earlier in her career, she gained international research experience as a Research Fellow at the Italian National Research Council (1990–1992) and as a Foreign Research Associate at Collège de France in Paris (1988–1989). Her scientific interests focus on neurotransmitter release mechanisms, receptor interactions, the effects of HIV-1 proteins and chemokines on central neurotransmission, synaptic function in multiple sclerosis, the neuro-immune interface, and the role of nutraceutics in brain health. She has led numerous national and international projects funded by the Italian Ministry of Research, Ministry of Health, and European programs, serving as principal investigator on studies addressing neuroinflammation, depression, synaptopathies, and the gut-brain axis. Proficient in English and French, in addition to her native Italian, Professor Pittaluga has made significant contributions to advancing pharmacological research with strong translational and clinical implications.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Correction: Vallarino et al. Healthy Properties of a New Formulation of Pomegranate-Peel Extract in Mice Suffering from Experimental Autoimmune Encephalomyelitis"

"Unveiling Niaprazine’s Potential: Behavioral Insights into a Re-Emerging Anxiolytic Agent"

"Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis"

"Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic"

"Presynaptic Release-Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720"

Jianxun Qi | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Jianxun Qi | Biological Networks | Best Researcher Award

Institute of Microbiology, Chinese Academy of Sciences | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianxun Qi laid a strong academic foundation in microbiology and virology, which paved the way for his remarkable contributions to structural biology and protein chemistry. His early focus was on understanding virus–host interactions, a field that would later define his scientific career and global recognition.

Professional Endeavors

Currently serving as a Professor at the Institute of Microbiology, Chinese Academy of Sciences (IMCAS), Dr. Qi has established himself as a leading scientist in viral pathogenesis and structural virology. In 2021, he was selected as a leading talent in science and technology innovation under China’s prestigious “Ten Thousand Talent Program.” His professional trajectory reflects dedication to advancing viral immunology and translational research with broad societal impact.

Contributions and Research Focus

Dr. Qi’s work centers on deciphering the structural mechanisms of virus–receptor interactions, shedding light on the molecular dynamics of pathogens such as Influenza virus, Coronaviruses, Ebola virus, Thogotovirus, ASFV, Coxsackievirus A10, and SFTSV. Through high-impact publications in Science, Nature, Cell, EMBO, PNAS, and Nature Communications, he has provided pivotal insights into viral entry, immune evasion, and vaccine design. Recent studies extend his expertise to epitope-based vaccine development and broad-spectrum antiviral engineering, offering innovative approaches to combat emerging infectious diseases.

Impact and Influence

With over 19,000 citations and an H-index of 64, Dr. Qi’s research has had a profound influence on the global scientific community. His findings have shaped understanding of pandemic threats, including MERS-CoV, SARS-CoV-2, and Ebola virus, directly informing vaccine strategies and therapeutic interventions. His recognition as a Highly Cited Researcher (2021–2024) and inclusion in Stanford University and Elsevier’s World’s Top 2% Scientists List underscore his international impact.

Academic Citations and Recognition

Dr. Qi’s groundbreaking studies—such as structural revelations on Influenza H7N9 (Science, 2013), MERS-CoV (Nature, 2013), and SARS-CoV-2 (Cell, 2020, 2022)—are extensively cited worldwide. His pioneering discoveries have garnered major honors, including the First Prize of the Beijing Science and Technology Award (2011) and the First Prize of the Chinese Preventive Medicine Association Science and Technology Award (2017).

Legacy and Future Contributions

Dr. Qi’s legacy lies in bridging fundamental virology with translational medicine, guiding the development of next-generation vaccines and antivirals. His continued exploration of viral mechanisms, coupled with collaborative innovations such as epitope vaccines and monoclonal antibody studies, positions him to contribute further to global preparedness against pandemics. Looking ahead, his research promises to expand the frontiers of viral immunology and structural vaccinology.

Conclusion

Dr. Jianxun Qi exemplifies scientific excellence through his persistent pursuit of knowledge, impactful research, and leadership in microbiology. His influential work on virus–host interactions and vaccine innovation has not only advanced academic discourse but also delivered tangible benefits to public health. As he continues to push boundaries in virology and immunology, his contributions will remain a cornerstone for future breakthroughs in infectious disease prevention and control.

Notable Publications

"T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots" 

"Enabling the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants including KP.2" 

  • Journal: Hlife
  • Citation: 5
  • Year: 2025

"Structural basis of DNA replication fidelity of the Mpox virus" 

"Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2" 

"Molecular mechanism of potently neutralizing human monoclonal antibodies against severe fever with thrombocytopenia virus infection" 

 

June Round | Biological Networks | Best Researcher Award 

Published on by Network Science

Dr. June Round | Biological Networks | Best Researcher Award 

University of Utah | United States

Author Profiles

Scopus

Google Scholar

Early Academic Pursuits

Dr. June Round’s academic journey reflects a foundation of dedication and scholarly excellence. Beginning with a B.S. in Biology (Cum Laude) at California Lutheran University, she distinguished herself early through departmental honors and multiple scholarships. Her passion for molecular biology led to an M.S. from the University of the Pacific, followed by a D.Phil. in Microbiology, Immunology, and Molecular Genetics at UCLA, supported by highly competitive fellowships. Her formative postdoctoral training at the California Institute of Technology under Sarkis K. Mazmanian provided a strong platform to explore the intricate interplay between microbiota and host immunity, setting the stage for her pioneering career.

Professional Endeavors

Currently serving as a Professor at the University of Utah, Dr. Round has held numerous leadership roles including Director of the Mountain West Microbiota Alliance (MoWMA) and Co-Director of the Microbiota and GI Immunology Consortia (MAGIC). She has chaired multiple search committees, overseen postdoctoral studies, and contributed extensively to university-level, college-level, and departmental governance. Her sustained involvement in NIH study sections, national symposia, and scientific advisory boards underscores her standing as a leader in immunology and microbial pathogenesis.

Contributions and Research Focus

Dr. Round’s research focuses on microbiota–immune system interactions, particularly their role in regulating immune tolerance and driving inflammatory diseases. Her laboratory has produced high-impact work elucidating mechanisms by which commensal microbes shape host immunity, contributing to transformative understanding in immunology, microbiology, and gastrointestinal health. Her investigations into toll-like receptors, dysbiosis, and immune regulation have provided new frameworks for therapeutic exploration in autoimmune and inflammatory disorders.

Impact and Influence

The significance of Dr. Round’s research is reflected in her numerous prestigious awards, including the NIH Innovator Award, Packard Fellowship, Pew Scholar Award, Burroughs Wellcome Investigator in Pathogenesis, and the W.M. Keck Research Award. These honors not only recognize her innovative contributions but also demonstrate her influence in shaping the field. She has trained and mentored a generation of young scientists, many of whom now serve as professors, researchers, and clinicians in leading institutions worldwide—an enduring testament to her academic leadership.

Academic Citations and Recognition

Dr. Round’s scholarship has been widely published in top-tier journals including Cell, Nature Reviews Immunology, Science Immunology, and Annual Review of Microbiology. Her reviews and original research articles are highly cited, frequently shaping discourse in immunology and microbiome research. Her contributions extend beyond publications through book chapters and invited conference proceedings, amplifying her thought leadership in the global scientific community.

Legacy and Future Contributions

Dr. Round’s legacy lies in bridging microbiology and immunology, redefining the microbiota’s role in human health and disease. Through her pioneering studies, administrative leadership, and mentorship, she has cultivated a scientific ecosystem that will continue to grow. Moving forward, her leadership in major microbiome initiatives and consortia is poised to advance translational breakthroughs, from novel therapeutics for autoimmune disease to deeper insights into the human–microbe interface.

Conclusion

Dr. June Round’s career reflects the hallmarks of an exceptional researcher: rigorous scholarship, innovative vision, academic leadership, and transformative mentorship. Her pioneering contributions to microbiome and immune system research have reshaped fundamental scientific understanding while fostering future leaders in biomedical science. With her remarkable impact, both in the laboratory and across academic institutions, Dr. Round stands as an exemplary candidate for the Best Researcher Award.

Notable Publications

"Neonatal fungi promote lifelong metabolic health through macrophage-dependent β cell development" 

  • Author: JH Hill, R Bell, L Barrios, H Baird, K Ost, M Greenewood, JK Monts
  • Journal: Science
  • Year: 2025

"The gut microbiome is associated with disease‐free survival in stage I–III colorectal cancer patients" 

  • Author: DA Byrd, V Damerell, MF Gomez Morales, SR Hogue, T Lin, J Ose
  • Journal: International Journal of Cancer
  • Year: 2025

"A microRNA-regulated transcriptional state defines intratumoral CD8+ T cells that respond to immunotherapy" 

  • Author: WW Tang, B Battistone, KM Bauer, AM Weis, C Barba, MZH Fadlullah
  • Journal: Cell reports
  • Year: 2025

"Primary tumor microbiomes predict distant metastasis of colorectal cancer" 

  • Author: B Parajuli, V Midya, R Kiddle, N De Jager, S Eggers, D Spakowicz
  • Journal: Cell reports
  • Year: 2025

"Clec12a controls colitis by tempering inflammation and restricting expansion of specific commensals" 

  • Author: TR Chiaro, M Greenewood, KM Bauer, KS Ost, E Stephen-Victor
  • Journal: bioRxiv
  • Year: 2025

Dmitry Guschin | Biological Networks |  Outstanding Research Achievement Award

Published on by Network Science

Dr. Dmitry Guschin | Biological Networks |  Outstanding Research Achievement Award

Sirius university of Science and Technology | Russia

Author Profiles

Oricd ID

Google Scholar

Early Academic Pursuits

Dr. Dmitry Guschin began his scientific journey in Moscow, Russia, where his early research as a Research Scientist at the Laboratory of Chromosome Structure (1990–1991) focused on the role of histone tails in maintaining chromatin structure during transcription. This pioneering work, published in Cell, laid the foundation for his long-term interest in chromatin dynamics and molecular mechanisms of gene regulation. His subsequent fellowship at the Imperial Cancer Research Fund in London (1991–1995) enabled him to uncover the role of Jak kinases in interferon signaling, a finding published in Nature. These formative years established his reputation as a molecular biologist with a keen ability to address fundamental questions in gene regulation.

Professional Endeavors

Throughout his career, Dr. Guschin has held prestigious positions across internationally recognized institutions. From visiting scientist roles at Argonne National Laboratory and the NIH, to his decade-long tenure at Sangamo BioSciences (2000–2014), he contributed to groundbreaking advances in genome editing. His later positions at the Institute of Basic Science in Korea (2015–2019), Moscow Institute of Physics and Technology (2019–2022), Ecole Polytechnique (2021), Nazarbaev University (2023–2024), and his current role as Lead Scientist at Sirius University (2024–) reflect a global career marked by innovation, collaboration, and leadership.

Contributions and Research Focus

Dr. Guschin’s research has consistently revolved around genome editing, chromatin biology, and translational medicine. At Sangamo BioSciences, he demonstrated targeted deletions using Zinc-Finger nucleases and developed methods for genome mutation detection, securing 10 U.S. patents. His contributions to CRISPR research at the Institute of Basic Science in Korea, where he engineered Cpf1 (CRISPR type V) proteins with novel PAM specificities, further advanced gene-editing precision. Additionally, his innovations in base editing and co-selection strategies positioned him as a thought leader in functional genomics.

Impact and Influence

The global trajectory of Dr. Guschin’s career underscores his broad scientific influence. His work has impacted both fundamental science-such as uncovering chromatin regulation mechanisms-and applied biotechnology, including methods adopted for therapeutic genome editing. His publications in Cell, Nature, Nature Biotechnology, and Science highlight the international recognition of his discoveries. Moreover, his patents and translational research contributions demonstrate lasting influence on both academia and industry.

Academic Citations

With over 20 peer-reviewed publications in top-tier journals, Dr. Guschin’s scholarship has been widely cited across molecular biology, biochemistry, and genome engineering fields. His publications not only advanced scientific discourse but also served as reference points for subsequent innovations in gene-editing technologies and cancer research.

Legacy and Future Contributions

Dr. Guschin’s legacy lies in bridging basic molecular discoveries with applied genome-editing technologies. His early contributions to chromatin biology and interferon signaling remain benchmarks in molecular biology, while his later work in Zinc-Finger nucleases and CRISPR engineering has influenced therapeutic development pipelines. In his current role at Sirius University, he continues to shape translational medicine by focusing on colloidal medicine and advanced biomedical applications. Looking forward, his expertise positions him to mentor future scientists and contribute to cutting-edge therapies in personalized medicine.

Conclusion

Dr. Dmitry Guschin’s career reflects a rare blend of scientific depth, technological innovation, and translational impact. From uncovering fundamental molecular mechanisms to pioneering genome-editing tools and mentoring the next generation, his contributions have left an indelible mark on modern biology. His ongoing work promises to expand the horizons of translational and personalized medicine, ensuring his influence will continue to grow in both academic and clinical domains.

Notable Publications

"Circulating Tumor DNA in Prostate Cancer: A Dual Perspective on Early Detection and Advanced Disease Management" 

  • Author: Stepan A. Kopytov; Guzel R. Sagitova; Dmitry Y. Guschin; Vera S. Egorova; Andrei V. Zvyagin; Alexey S. Rzhevskiy
  • Journal: Cancers
  • Year: 2025

"Modern approaches to engineering human reporter cell lines using CRISPR within Safe Harbor loci and endogenous genes" 

  • Author: A. G. Bykonya; D. Y. Guschin; N. A. Barlev
  • Journal: Critical Reviews in Biotechnology
  • Year: 2025

"Vinculin–Arp2/3 interaction inhibits branched actin assembly to control migration and proliferation" 

  • Author: John James; Artem I Fokin; Dmitry Y Guschin; Hong Wang; Anna Polesskaya; Svetlana N Rubtsova; Christophe Le Clainche; Pascal Silberzan; Alexis M Gautreau; Stéphane Romero
  • Journal: Life Science Alliance
  • Year: 2025

"BRCA Mutations-The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers" 

  • Author: Loboda, Anna P.; Adonin, Leonid S.; Zvereva, Svetlana D.; Guschin, Dmitri Y.; Korneenko, Tatyana V.; Telegina, Alexandra V.; Kondratieva, Olga K.; Frolova, Sofia E.; Pestov, Nikolay B.; Barlev, Nick A.
  • Journal: International Journal of Molecular Sciences
  • Year: 2023

"Vinculin-Arp2/3 Interaction Inhibits Branched Actin Assembly to Control Cell Migration and Cell Cycle Progression" 

  • Author: John James; Artem I. Fokin; Dmitry Y. Guschin; Hong Wang; Anna Polesskaya; Svetlana N. Rubtsova; Christophe Le Clainche; Pascal Silberzan; Alexis M. Gautreau; Stéphane Romero
  • Journal: Preprint
  • Year: 2023

 

 

Zhengyang Guo | Metabolism Networks | Best Researcher Award

Published on by Network Science

Dr. Zhengyang Guo | Metabolism Networks | Best Researcher Award

Peking University Third Hospital | China

Author Profile 

Scopus

Early Academic Pursuits

Zhengyang Guo’s academic journey began with a strong foundation in the life sciences. He earned his Bachelor’s degree from the School of Basic Medical Sciences at Peking University, which provided him with comprehensive knowledge in biomedical sciences. His pursuit of higher education continued at the Department of Microbiology, Peking University, where he obtained his M.D. degree. This academic background not only reflects his commitment to advancing medical research but also highlights the interdisciplinary foundation that shaped his later contributions in oncology and immunology.

Professional Endeavors

Currently serving as an Assistant Professor at Peking University Third Hospital, Guo has dedicated his professional career to the study of tumor biology and clinical translational research. Alongside his teaching responsibilities, he actively contributes to developing cutting-edge techniques through his involvement in the immunology platform and guiding graduate students in experimental teaching. His professional endeavors balance research, teaching, and technological development, underlining his role as both a researcher and mentor.

Contributions and Research Focus

Dr. Guo’s research primarily centers on tumor epigenetics, tumor metabolism, and the tumor microenvironment. His innovative work investigates molecular mechanisms that influence cancer progression and therapeutic outcomes. Specifically, he has focused on targeting the enzyme SCD1 in combination with EZH2 inhibitors to enhance the efficacy of melanoma treatment and immunotherapy. His projects, supported by prestigious funding bodies such as the National Natural Science Foundation of China and Peking University Medicine Fund, reflect both the clinical relevance and scientific novelty of his work.

Impact and Influence

As an active contributor to the global scientific community, Guo holds membership in the Biophysical Society of China and the Chinese Society of Biochemistry and Molecular Biology. His expertise is recognized internationally, as he serves as a peer reviewer for high-impact journals including Experimental Hematology & Oncology, Cell Communication and Signaling, Apoptosis, and Lipids in Health and Disease. These engagements highlight his influence in shaping scientific dialogue and advancing standards in cancer research.

Academic Cites and Intellectual Property

Guo’s research impact extends beyond publications into intellectual property and patents. He is a co-inventor on multiple patents related to antitumor drug compositions involving EZH2 and SCD1 inhibitors, as well as novel approaches to treating liver cancer using diacylglycerol kinase γ. These patents underscore the translational potential of his work, bridging basic molecular research with therapeutic innovation. His contributions are already shaping new pathways in drug discovery and cancer therapy.

Legacy and Future Contributions

With a strong foundation of academic excellence, innovative research, and translational breakthroughs, Guo is poised to make long-lasting contributions to the field of oncology. His ongoing efforts in epigenetic regulation, tumor metabolism, and immunotherapy strategies hold promise for redefining cancer treatment paradigms. By mentoring future scholars and fostering collaborations across disciplines, he is actively building a legacy that will continue to influence both academia and clinical practice.

Conclusion

In summary, Dr. Zhengyang Guo exemplifies the qualities of a modern medical researcher-a scholar who bridges fundamental biology with clinical application. His journey from early academic pursuits to groundbreaking research in tumor biology reflects dedication, innovation, and leadership. With multiple funded projects, patents, and international recognition, his work significantly impacts the scientific community and promises future advancements in cancer treatment. His career trajectory positions him as a leading figure in biomedical research, with the potential to transform cancer therapy at both national and global levels.

Notable Publications

"3G Internet Diffusion and Secondary Education Attainment: Evidence of Opportunity Cost in Vietnam" 

  • Author: Trang Thi Pham; Bernardo Caldarola
  • Journal: Review of Development Economics
  • Year: 2025

 

 

Rishi Pandey | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Rishi Pandey | Biological Networks | Best Researcher Award

Western Sydney University | Australia

Author Profile

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Rishi Pandey began his journey in the field of science with a deep-rooted passion for biochemistry and analytical chemistry. His foundational academic experiences were marked by a strong inclination toward research and laboratory-based innovations. He cultivated his scientific rigor early, focusing on the integration of chemical principles with biological applications, which laid the groundwork for his later success in biosensor development and molecular diagnostics.

PROFESSIONAL ENDEAVORS

With over a decade of impactful professional experience, Rishi Pandey has held key roles across academia, government-funded research institutions, and biotech start-ups. Currently serving as the Research Manager at the School of Medicine, Western Sydney University, he leads the Mass Spectrometry and Next-Gen Sequencing research platforms. He has also held pivotal roles at Eurofins NZ, Manuka Health Ltd., and Eve Health Labs, where he managed high-value analytical projects, developed cutting-edge testing methods, and led cross-functional teams. His career reflects a strategic balance between scientific depth and operational leadership.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOLOGICAL NETWORK

Rishi Pandey's research interests span analytical chemistry, proteomics, biosensor development, molecular diagnostics, and the application of machine learning for scientific innovation. He is notably recognized for developing an electrochemical biosensor device for point-of-contact drug testing-an innovation that earned him the 2021 KiwiNet Emerging Innovator Award. His leadership in engineering protein-based antiviral candidates and establishing platforms for forensic identification and gut health metabolomics have led to several successful translational research outcomes. He also contributed to the establishment of analytical laboratories and the integration of LEAN and Agile methodologies for efficient scientific workflows.

IMPACT AND INFLUENCE

Rishi Pandey has significantly influenced the scientific and industrial communities by bridging the gap between academic research and commercial science. His leadership has accelerated the development of cost-effective diagnostic and testing solutions, saving organizations hundreds of thousands of dollars. His training programs for postgraduate students and researchers in advanced analytical techniques have elevated the skill sets of future scientists. Moreover, his collaborative partnerships with research institutes in Australia, New Zealand, and the U.S. have facilitated global innovation in biosciences.

ACADEMIC CITES

While specific citation metrics are not disclosed here, Rishi Pandey’s body of work in proteomics, analytical method development, and biosensors contributes to high-impact fields such as forensic science, public health diagnostics, and functional food analytics. His contributions have been instrumental in fostering impactful publications and enabling the development of competitive research proposals within academic and industrial settings.

LEGACY AND FUTURE CONTRIBUTIONS

Rishi Pandey’s legacy is one of translational excellence, scientific curiosity, and strategic leadership. His continued efforts to fuse biochemical research with AI-driven data mining and diagnostics position him as a thought leader in the emerging landscape of precision medicine and bioanalytical technology. Looking forward, his contributions are expected to expand the accessibility of rapid diagnostics, foster global research collaborations, and inspire a new generation of biochemists focused on science commercialization for societal benefit.

OTHER IMPORTANT HIGHLIGHTS

  • Recognized by KiwiNet as an Emerging Innovator for proteomics and biosensor innovations.

  • Spearheaded commercial laboratory growth at Eve Health Labs to exceed $350,000 in annual revenue.

  • Developed and validated critical testing methodologies for high-value nutraceuticals and food safety at Eurofins NZ and Manuka Health Ltd.

  • Expertise spans across analytical instruments such as Thermo Orbitrap, SCIEX, Waters LCMS/MS, and Bruker Q-TOF, contributing to robust quality and analytical assurance.

  • Played a key role in industry-academia interface, fostering cross-border collaborations and industry-aligned research deliverables.

NOTABLE PUBLICATIONS

"Electrochemical Aptamer-Based Biosensors for Cocaine Detection in Human Saliva: Exploring Matrix Interference" 

  • Author: Y Liu, R Pandey, MJ McCarthy, O Raymond
  • Journal: Analytical Chemistry
  • Year: 2025

"Nanoparticle based antigen detection of norovirus in human faecal samples: A proof-of-concept study" 

  • Author: R Pandey, P Gyawali, MAT Blaskovich, KC Sanjaya
  • Journal: Nanoparticle based antigen detection of norovirus in human faecal samples: A proof-of-concept study
  • Year: 2025

"UHPLC and Computational Studies of Chemical Constituents Derived from Myrica esculenta against NADPH Oxidase 2 (NOX2) Protein" 

  • Author: AR Pandey, WA Ansari, P Maurya, H Aslam, RR Pandey, DP Mishra
  • Journal: ChemistrySelect
  • Year: 2025

"Single-Use Electrochemical Aptamer-Based Sensors for Calibration-Free Measurements in Human Saliva via Dual-Frequency Approaches: Prospects and Challenges" 

  • Author: Y Liu, R Pandey, MJ McCarthy, O Raymond
  • Journal: Analytical Chemistry
  • Year: 2025

"Hydrochar from agrowastes: a low-cost adsorbent for environmental application" 

  • Author: RR Pandey, AR Pandey, AK Tripathi, J Kumar
  • Journal: Role of Green Chemistry
  • Year: 2024

Dimitrios G. Tsoukas | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Dimitrios G. Tsoukas | Biological Networks | Best Researcher Award

Mitera Hospital Athens | Greece

Author Profile

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Dr. Dimitrios G. Tsoukas began his academic journey with exceptional distinction, graduating with a Bachelor in Medicine from the National and Kapodistrian University of Athens Faculty of Medicine. His early academic excellence set the foundation for a career rooted in clinical precision and innovative thinking. His education emphasized not only traditional orthopaedic surgery but also introduced him to minimally invasive techniques, which would later define his clinical signature.

PROFESSIONAL ENDEAVORS

Dr. Tsoukas's professional career spans over two decades of dynamic clinical and academic leadership. Currently, he serves as the Director of the E’ Orthopaedic Clinic for Advanced Arthroscopic Sports and Regenerative Surgery at MITERA Hospital (HH Group). He is also an Adjunct Professor at the University of Nebraska-Lincoln (USA) and has held numerous leadership positions at top hospitals across Greece and Cyprus. His pioneering efforts led to the founding of MIOSMED Center, an internationally recognized teaching hub endorsed by ISAKOS, ESSKA, and ICRS, and the Elite Regenerative Clinic Athens, a Lipogems SpA Center of Excellence. His clinical footprint spans not only orthopaedics but also women’s health, athletic injuries, and sports medicine innovation.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOLOGICAL NETWORKS

Dr. Tsoukas is a distinguished authority in arthroscopic, minimally invasive, and regenerative orthopaedic surgery, with special emphasis on adipose-derived stem cell applications for arthritis and joint degeneration. His contributions include advanced biological techniques in cartilage regeneration, joint preservation, and tendon repair. He has played a leading role in global education by serving as a certified instructor for ESSKA, contributing to simulation-based medical training, and mentoring young surgeons. His research interests include low-cost arthroscopy simulators, stem cell therapies, sports injury prevention in children, and medical device innovation.

IMPACT AND INFLUENCE

Dr. Tsoukas is recognized as a Key Opinion Leader (KOL) in orthopaedics and regenerative medicine, actively shaping clinical best practices and treatment protocols. His influence is reflected through editorial board memberships, reviewer roles for high-impact journals like the British Journal of Sports Medicine and the Orthopaedic Journal of Sports Medicine, and his participation in international regulatory and scientific committees. His appointment as a TEDx speaker in Kigali, Rwanda (2023) further underscores his role in global medical outreach and inspiration.

ACADEMIC CITES

As a scientific collaborator, Dr. Tsoukas has contributed to various institutions including the Athens University Medical School, Medical Physics Laboratory Simulation Center, and the European University of Cyprus. He has been involved in academic teaching, research, and publication, significantly advancing clinical education in Europe and the United States. He also served as Editor-in-Chief of the Journal of Stem Cell Research, and is a respected peer reviewer, ensuring academic rigor across multiple orthopaedic publications.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Dimitrios G. Tsoukas’s legacy is deeply embedded in medical innovation, education, and regenerative orthopaedics. As a fellow member of ICRS (2024) and an American Board of Regenerative Medicine Diplomat, he continues to push the boundaries of biological orthopaedic science. His ongoing leadership in global campaigns like “STOP Sports Injuries in Children” and collaborative research with biotechnology leaders like Terumo BCT, Arthrex, and Lipogems positions him as a visionary in the future of personalized, minimally invasive care. His legacy will endure through the institutions he built, the surgeons he trained, and the global initiatives he leads.

HONORS AND RECOGNITIONS

Dr. Tsoukas has received numerous accolades recognizing his contributions to orthopaedic science and Greek athletics. Among these are the Silver Award for Surgical Innovation at the Boussias Healthcare Business Awards 2021, the Med Professionals Honor for Stem Cell Innovation (2022), and several sports awards acknowledging his contributions to Greek basketball and volleyball. He holds the rare distinction of being enlisted in the Guinness World Records for medical contributions to the record-setting Athinaikos female basketball team.

OTHER SIGNIFICANT AFFILIATIONS AND LICENSES

Dr. Tsoukas maintains international medical licensure in Switzerland and Dubai, and continues to collaborate with organizations such as ECOSEP, CEV, and Smith & Nephew’s European Knee Advisory Board. These affiliations highlight his global reach and his role in shaping orthopaedic protocols across continents. His role as Head Doctor for National and Professional Teams underscores his credibility and trust within elite athletic circles.

NOTABLE PUBLICATIONS

"Prospective Observational Study of a Non-Arthroscopic Autologous Cartilage Micrografting Technology for Knee Osteoarthritis" 

  • Author: Dimitrios Tsoukas; Ilie Muntean; Christos Simos; Ruben Sabido-Vera
  • Journal: Bioengineering
  • Year: 2023

Eddie Wampande | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Eddie M. Wampande | Biological Networks | Best Researcher Award

Makerere University | Uganda

Author Profile

Scopus

Google Scholar

DR. EDDIE M. WAMPANDE: A VISIONARY IN INFECTIOUS DISEASE EPIDEMIOLOGY AND VETERINARY SCIENCE

EARLY ACADEMIC PURSUITS

Dr. Eddie M. Wampande began his academic journey with a scholarship awarded by the Government of Uganda to pursue a Bachelor’s Degree in Veterinary Medicine (BVM) at Makerere University from 1993 to 1998. Driven by a strong passion for infectious diseases and parasitology, he advanced to complete a Master’s degree in Molecular Biology (Parasitology) at the same university with a WHO/TDR scholarship. His academic accomplishments culminated in a Ph.D. in Molecular Epidemiology of Infectious Diseases, with a focus on the phenotypes and microevolution of Mycobacterium tuberculosis, supported by the Tuberculosis Research Unit (TBRU), Case Western Reserve University, Cleveland.

PROFESSIONAL ENDEAVORS

Dr. Wampande’s professional journey has been deeply intertwined with Makerere University. He began as a Research Assistant (2000–2002) in the Molecular Biology Laboratory and gradually progressed to Research Associate (2002–2005) and later Senior Lecturer (2005 to date). In 2012, he joined the University of Basel’s Swiss Tropical Institute and Public Health as a Research Fellow, and since 2014, he has been serving as the Director of the Central Diagnostic Laboratory. His commitment to capacity building is evident in his leadership of diagnostic and research programs, reflecting strong administrative and technical expertise.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOLOGICAL NETWORKS

Dr. Wampande's primary research focus is on the molecular epidemiology of infectious pathogens of both economic and public health significance, such as Mycobacterium tuberculosis, African Swine Fever Virus, Trypanosoma brucei, and antimicrobial-resistant pathogens. He has supervised 15 MSc students to completion, covering diverse research areas including tuberculosis genotyping, HIV diagnosis, zoonotic transmission, and antibiotic resistance. His Ph.D. mentorship includes completed theses and ongoing research projects related to TB-HIV co-infections and antimicrobial resistance dynamics in poultry farms. He has also served as external examiner for Ph.D. theses from other countries, evidencing his continental influence.

IMPACT AND INFLUENCE

Dr. Wampande has been instrumental in multiple resource mobilization efforts, securing national and international grants totaling over USD 1.3 million, supporting projects ranging from vector-borne diseases to molecular diagnostics and zoonotic infections. He led the “Stamp Out Sleeping Sickness” initiative in Eastern Uganda (2010–2015) and coordinated large-scale field surveys such as the serological bovine tuberculosis survey in Karamoja (2022) and control programs targeting tick and bacterial resistance (2015–2019). His work has directly impacted national policy on disease surveillance, diagnostics, and animal-human health interface management.

ACADEMIC CITES

His scholarly work and technical reviews have earned him appointments such as Reviewer for the International Journal of Tuberculosis and Lung Diseases (2015–2017) and BMC Infectious Diseases (2017–2020). He is a member of several key scientific bodies, including the Genome Analysis Working Group and Microbiome Working Group under H3Africa, a continent-wide initiative promoting genomic research. His contributions to genome bioinformatics were further recognized by a three-month fellowship at Baylor College of Medicine, USA, funded by the MRC/UVRI Infection and Immunity Program.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Wampande’s legacy lies in his consistent dedication to training the next generation of African scientists, advancing research infrastructure, and deepening our understanding of infectious disease epidemiology. His participation in global initiatives like the THRiVE Program (Welcome Trust, UK) and Cambridge Africa’s Alborado Research Scheme underlines his commitment to collaborative science. Looking ahead, his ongoing Ph.D. supervision, continuous research in African Swine Fever epidemiology, and further exploration of zoonotic diseases place him in a pivotal role in shaping Africa's public health research landscape.

OTHER NOTABLE TOPICS

HONORS AND FELLOWSHIPS
Dr. Wampande has received numerous accolades, including the Makerere University Research Award for Excellence, Welcome Trust Postdoctoral Fellowship, and Gates Foundation Travel Grant.

COMMUNITY ENGAGEMENT
He remains an advocate for community-inclusive scientific approaches, using participatory methods to combat diseases and ensure sustainable practices in animal husbandry, agriculture, and diagnostics across Uganda.

RESOURCE MOBILIZATION EXPERTISE
He has led and co-led research projects funded by major organizations such as the United States Department of Agriculture, Defence Threat Reduction Agency, and the WHO/TDR, contributing to cross-sectoral innovation and knowledge application in both academic and governmental contexts.

NOTABLE PUBLICATIONS

"A description of the clinical signs and lesions of African swine fever, and its differential diagnoses in pigs slaughtered at selected abattoirs in central Uganda" 

  • Author: JE Ekakoro, A Nassali, C Hauser, K Ochoa, D Ndoboli, R Okwasiimire
  • Journal: Frontiers in Veterinary Science
  • Year: 2025

"Detection and molecular characterisation of fowl adenovirus associated with inclusion body hepatitis and hydropericardium syndrome in Uganda" 

  • Author: W Eneku, R Okwasiimire, F Mutebi, M Kisekka, S Kakooza, M Afayoa
  • Journal: Tropical Animal Health and Production
  • Year: 2025

"Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda" 

  • Author: DP Kateete, S Namakula, E Kigozi, FA Katabazi, GW Kasule, K Musisi
  • Journal: bioRxiv
  • Year: 2025

"Hepatoprotective effect of methanol fruit extract of Punica granatum L in highly active antiretroviral therapy-induced toxicity in Wistar rats" 

  • Author: E Kwizera, EM Wampande, CD Kato, P Mujinya, A Wandera, F Bwambale
  • Journal: Drug and Chemical Toxicology
  • Year: 2024

"Polymorphisms in immune genes and their association with tuberculosis susceptibility: An analysis of the African population" 

  • Author: W Wodelo, EM Wampande, A Andama, DP Kateete, K Ssekatawa
  • Journal: The Application of Clinical Genetics
  • Year: 2024